awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35048323-86FF3512-D0F5-4BCF-861E-564DC9A6B852
Q35048323-86FF3512-D0F5-4BCF-861E-564DC9A6B852
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35048323-86FF3512-D0F5-4BCF-861E-564DC9A6B852
Adjuvant therapy for high-risk primary and resected metastatic melanoma.
P2860
Q35048323-86FF3512-D0F5-4BCF-861E-564DC9A6B852
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35048323-86FF3512-D0F5-4BCF-861E-564DC9A6B852
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
52a88fc851f9121ab06d2832d3dbde2c21bc69a0
P2860
Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma.